Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hepatitis

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.

Viral Hepatitis I: Introduction

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Droplet Digital PCR Measurement of HBV DNA in On-Treatment Chronic HBV Patients: Association With HCC Development and Outcomes.

Journal of viral hepatitis·2026

Same author

APASL clinical practice guidelines on the management of chronic hepatitis B infection: a 2026 update.

Hepatology international·2026

Same author

Efficacy of an Online Meaning-Centered Psychotherapy in Caregivers of Advanced Cancer (eMCP-C): A Mixed-Method Pilot Randomized Controlled Trial.

Psycho-oncology·2026

Same author

Feasibility, acceptability, and preliminary efficacy of Tai Chi versus mindful yoga on psycho-spiritual distress in patients with advanced cancer: A mixed-method pilot randomized controlled trial.

European journal of oncology nursing : the official journal of European Oncology Nursing Society·2026

Same author

Longitudinal Profile of HBsAg Isoforms and Circulating Immune Complexes in the Natural History of Chronic Hepatitis B Infection.

Journal of clinical and translational hepatology·2025

Same author

Loneliness and Its Mediating Relationship With Depression, Social Support, and Quality of Life Among Long-Term Care Facility Residents.

Journal of advanced nursing·2025

Search research articles

Related Experiment Video

Updated: Apr 28, 2026

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Published on: December 15, 2023

Artificial neural network accurately predicts hepatitis B surface antigen seroclearance.

Ming-Hua Zheng¹, Wai-Kay Seto², Ke-Qing Shi³

¹Department of Infection and Liver Diseases, Liver Research Center, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China; Department of Medicine, the University of Hong Kong, Queen Mary Hospital, Hong Kong, China.

|June 11, 2014

Summary

Artificial neural networks (ANNs) accurately predict Hepatitis B surface antigen (HBsAg) seroclearance in chronic hepatitis B (CHB) patients using serum data. ANNs show higher accuracy than traditional models for predicting HBsAg seroclearance.

More Related Videos

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

Related Experiment Videos

Last Updated: Apr 28, 2026

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Published on: December 15, 2023

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

Area of Science:

Hepatology
Artificial Intelligence in Medicine
Biostatistics

Background:

Chronic hepatitis B (CHB) management focuses on favorable outcomes like Hepatitis B surface antigen (HBsAg) seroclearance and seroconversion.
Predicting these outcomes aids in personalized treatment strategies for CHB patients.

Purpose of the Study:

To develop and validate artificial neural networks (ANNs) for predicting HBsAg seroclearance and seroconversion in CHB patients.
To compare the predictive accuracy of ANNs against logistic regression models (LRMs) and individual serum markers.

Main Methods:

Analysis of serum data from 203 untreated, HBeAg-negative CHB patients with spontaneous HBsAg seroclearance and 203 matched controls.
Development and testing of ANNs and LRMs for predicting HBsAg seroclearance and seroconversion.
Assessment of predictive accuracy using the area under the receiver operating characteristic curve (AUROC).

Main Results:

ANNs demonstrated high AUROCs (0.93-0.96) for predicting HBsAg seroclearance, significantly outperforming LRMs and individual markers.
For HBsAg seroclearance, quantitative HBsAg (qHBsAg) and HBV DNA levels and their reduction were key predictors.
ANN performance for HBsAg seroconversion (AUROC 0.757) was lower but still showed a trend of superiority over LRMs and individual markers.

Conclusions:

ANNs provide a highly accurate method for identifying spontaneous HBsAg seroclearance in CHB patients using readily available serum data.
Further research is needed to identify more effective predictors for HBsAg seroconversion.